📊 Analyst Consensus & Targets
- Analyst Rating: Buy
- Price Target: $197.33333
- Sector: Healthcare – Diagnostics & Research
💡 The Growth Thesis
Buy Consensus: Charles River Laboratories International, Inc. Analysts project a -1.1% potential upside. Currently trading at a Forward P/E of 18.237654.